Form 4: DSS, Inc. Reduces Stake in Impact Biomedical Inc.

DSS, Inc. reports the sale of Impact Biomedical Inc. common stock through a series of transactions, reducing its direct and indirect holdings.

Summary

• DSS, Inc. filed a Form 4 detailing changes in beneficial ownership of Impact Biomedical Inc. common stock.
• On March 21, 2025, DSS, Inc. indirectly disposed of 166,600 shares each through DSS Securities, Inc., DSS BlockChain Security, Inc., and DSS BioHealth Security, Inc. at a price of $3.3004 per share.
• On March 26, 2025, DSS, Inc. directly disposed of 48,281 shares at $3.1292 per share and 9,858 shares at $3.15 per share.
• On March 27, 2025, DSS, Inc. directly disposed of 47,681 shares at $2.5011 per share.
• Following these transactions, DSS, Inc. directly owns 1,051,800 shares and indirectly owns 1,178,882 shares through DSS BioHealth Security, Inc.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the reduction in DSS, Inc.'s stake, which could indicate a lack of confidence in Impact Biomedical Inc.'s future prospects.

Negatives

• DSS, Inc. reduced its stake in Impact Biomedical Inc., which could be perceived negatively by investors.

Risks

• Continued selling pressure from DSS, Inc. could further depress the price of Impact Biomedical Inc. stock.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders trade shares of a publicly traded company. These filings are closely watched by investors for insights into the sentiment and actions of those with privileged information.

Stakeholder Impact

• Shareholders may react negatively to the news of DSS, Inc. reducing its stake.
• The stock price of Impact Biomedical Inc. could be negatively impacted.

Key Dates

Keywords

Impact Biomedical Inc., DSS, Inc., Form 4, Beneficial Ownership, Stock Sale